Response Biomedical
Industry
- Medical Devices
- Diagnostic Equipment & Supplies
- In Vitro Diagnostics
- Biotechnology
Latest on Response Biomedical
New At The Helm Company Changes ADAMS , Adrian To: Aralez Pharmaceuticals Inc. , CEO (June) From: Auxilium Pharmaceuticals Inc., Pres. & CEO Phone: 919-913-1030 ADAMS , Gregory, PhD To: Vive
Company Changes BAROUSSE , Clark To: Biolase Inc. , SVP, Worldwide Sales & Account Mgmt. (August) From: Hybridge LLC, Pres. Phone: 888-424-6527 CONSTANTINE , Wilson To: Nihon Kohden America
A look at financing, M&A, and alliance activity April-June 2011 In this issue, we present another installment of our quarterly review of device/diagnostics dealmaking – for the second quarter of 2011.
Mergers & Acquisitions /In Vitro Diagnostics Clovis Oncology Inc. Roche Roche Diagnostics Roche Molecular Systems Inc. On the same day it received rights to a solid tumor compound from Pfizer Inc.